The 5-year OS rates were 46% in the HIPEC group versus 38% in the no-HIPEC group, they noted in Lancet Oncology. The trial ...

The median patient age was 54 years, 77.8% of patients had stage III disease, and 88.6% had serous ovarian cancer. The ...

Life Expectancy with Stage 4 Cancer How long a person lives depends on the type of cancer. Some cancers are aggressive, have ...

Oncoinvent Announces Promising Interim Results for Radspherin® as a Potential Treatment for Peritoneal Carcinomatoses ...

Background Peritoneal metastasis is the most common metastasis pattern of gastric cancer. Patients with gastric cancer ...